Inventor · disambiguated record
Yaacov Herzig
Also filed as: HERZIG YAACOV
16 granted patents·6 pending applications·581 citations·filing 1994–2011
95Inventor score
Top patents by PatentIndex Score
22 records- 0197US5877218ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Mar 2, 1999·153 cites·19 claims
- 0295US6528685B2Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1999·Granted Mar 4, 2003·47 cites·25 claims
- 0395US5914349ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Jun 22, 1999·50 cites·18 claims
- 0495US5877221ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Mar 2, 1999·52 cites·29 claims
- 0595US5466683AWater-soluble analogs of carbamazepineTEVA PHARMA·Filed 1994·Granted Nov 14, 1995·74 cites·17 claims
- 0694US5994408ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Nov 30, 1999·54 cites·32 claims
- 0793US5880159ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Mar 9, 1999·47 cites·29 claims
- 0891US6271263B1Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1999·Granted Aug 7, 2001·35 cites·21 claims
- 0977US5880157ADerivatives of tetramethylcyclopropaneYISSUM RES DEV CO·Filed 1995·Granted Mar 9, 1999·17 cites·24 claims
- 1075US5646188APolyamine derivatives of 1-aminoindanTEVA PHARMA·Filed 1995·Granted Jul 8, 1997·46 cites·41 claims
- 1171US7625946B2Propargylated aminoindans, processes for preparation, and uses thereofYISSUM RES DEV CO·Filed 2007·Granted Dec 1, 2009·2 cites·7 claims
- 1267US8759382B2Propargyl-trifluoromethoxy-aminobenzothiazole derivatives, their preparation and useFALB ELIEZER·Filed 2011·Granted Jun 24, 2014·1 cites·17 claims
- 1367US8609719B2Propargylated aminoindans, processes for preparation, and uses thereofPIRYATINSKY VICTOR·Filed 2009·Granted Dec 17, 2013·1 cites·10 claims
- 1466US7964751B2Enantiomers of amino-phenyl-acetic acid octadec-9-(Z) enyl ester, their salts and their usesYEDA RES & DEV·Filed 2008·Granted Jun 21, 2011·1 cites·10 claims
- 1559US2009131535A1Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitorsTEVA PHARMA·Filed 2009·Application pending·0 cites
- 1654US8987263B2Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agentsSHINITZKY MEIR·Filed 2003·Granted Mar 24, 2015·1 cites·17 claims
- 1748US2004010038A1Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitorsFiled 2003·Application pending·0 cites
- 1845US2005197365A1Diamino thiazoloindan derivatives and their useFiled 2005·Application pending·0 cites
- 1943US7294739B1Basic amine esters or oleic acid and their use as anti-inflammatory or immunobodulatory agentsTEVA PHARMACAETICAL IND LTD·Filed 2006·Granted Nov 13, 2007·0 cites·21 claims
- 2041US2007021450A1Indanylamino uracils and their use as antioxidants and neuroprotectantsSKLARZ BENJAMIN·Filed 2005·Application pending·0 cites
- 2139US2004176430A1Propargyl-trifluoromethoxy-amino-benzothiazole derivativesFiled 2003·Application pending·0 cites
- 2238US2006025446A1Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disordersSTERLING JEFFREY·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →